Skip to main content

Sleep Disorders

The orexin receptor antagonist lemborexant (Dayvigo) has been approved by the US Food and Drug Administration for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adults, Eisai Co. announced.
Treating depression in patients with comorbid insomnia is associated with improved insomnia symptoms, new research shows.
Karl Doghramji, MD, Medical Director of the Jefferson Sleep Disorders Center in Philadelphia shares tips for choosing insomnia treatments for older patients with dementia.
Adults who reported declining sleep quality in their 40s and 50s had more beta-amyloid protein in their brains later in life, positron emission tomography brain scans revealed.
Soldiers who have insomnia before deployment may be more likely to develop post-traumatic stress disorder (PTSD) or experience suicidal thoughts than service members who don't have insomnia before they deploy, a U.S. study suggests.
Back to Top